https://www.mangaloremirror.com/positive-results-from-proderm-study-of-octagam-10-in-patients-with-dermatomyositis-meeting-the-primary-endpoint-will-be-presented-at-acr-convergence-2020/
Positive Results From ProDERM Study of octagam® 10% in Patients With Dermatomyositis Meeting the Primary Endpoint Will Be Presented at ACR Convergence 2020